Save time and get answers to complex questions with AI chat
Pramlintide approval date?How much is mebendazole?Alogliptin benzoate cost?Allergan's patent for latisse expired?Bortezomib market france?
See the DrugPatentWatch profile for atovaquone
Atovaquone is not classified as an antibiotic. It’s an antiprotozoal/antimalarial medication used to treat infections caused by organisms like Pneumocystis jirovecii (pneumocystis pneumonia, often alongside other drugs) and malaria-related conditions, depending on the regimen.
Antibiotics are typically used to treat bacterial infections, and they work against bacteria. Atovaquone’s uses are aimed at protozoa and related parasites rather than bacteria.
In practice, people most often encounter atovaquone for: - Pneumocystis pneumonia (commonly as part of combination therapy) - Malaria (as an antimalarial option in specific treatment contexts)
If the goal is to identify whether it treats bacteria: no. If the goal is to identify whether it treats protozoal/parasite infections: yes.
Other Questions About Atovaquone :